$PRPO
Precipio, Inc.

2012 Q4 Form 10-Q Financial Statement

#000104396112000016 Filed on November 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $7.292M $7.889M $8.253M
YoY Change -14.92% -4.41% 86.76%
Cost Of Revenue $5.630M $4.089M $3.808M
YoY Change 71.12% 7.38% 58.53%
Gross Profit $3.544M $3.800M $4.445M
YoY Change -32.92% -14.51% 120.38%
Gross Profit Margin 48.6% 48.17% 53.86%
Selling, General & Admin $4.310M $5.559M $4.364M
YoY Change -11.68% 27.38% 102.13%
% of Gross Profit 121.61% 146.29% 98.18%
Research & Development $620.0K $668.0K $515.0K
YoY Change 8.77% 29.71% -15.99%
% of Gross Profit 17.49% 17.58% 11.59%
Depreciation & Amortization $710.0K $495.0K $481.0K
YoY Change 20.34% 2.91% 243.57%
% of Gross Profit 20.03% 13.03% 10.82%
Operating Expenses $4.930M $6.227M $4.884M
YoY Change -9.37% 27.5% 71.73%
Operating Profit -$1.386M -$2.427M -$439.0K
YoY Change 782.8% 452.85% -46.92%
Interest Expense $1.020M -$210.0K -$240.0K
YoY Change -525.0% -12.5%
% of Operating Profit
Other Income/Expense, Net -$10.00K -$6.000K -$2.000K
YoY Change -101.2% 200.0%
Pretax Income -$2.260M -$2.640M -$1.279M
YoY Change -625.58% 106.41% 54.66%
Income Tax $60.00K $114.0K -$9.000K
% Of Pretax Income
Net Earnings -$2.314M -$2.754M -$1.270M
YoY Change -976.52% 116.85% 41.43%
Net Earnings / Revenue -31.73% -34.91% -15.39%
Basic Earnings Per Share
Diluted Earnings Per Share -$231.0M -$275.0M -$127.0M
COMMON SHARES
Basic Shares Outstanding 71.65M shares 71.65M shares 49.32M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.500M $8.750M $1.420M
YoY Change -9.09% 516.2% -69.06%
Cash & Equivalents $4.497M $4.747M $1.423M
Short-Term Investments $4.000M
Other Short-Term Assets $1.047M $1.186M $1.336M
YoY Change 27.68% -11.23% 105.54%
Inventory $5.092M $4.406M $3.306M
Prepaid Expenses
Receivables $8.081M $8.157M $7.591M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.72M $22.49M $13.66M
YoY Change 8.83% 64.72% 9.86%
LONG-TERM ASSETS
Property, Plant & Equipment $2.190M $2.091M $1.597M
YoY Change 18.0% 30.93% 52.1%
Goodwill $6.918M $6.674M $6.275M
YoY Change 7.42% 6.36%
Intangibles $10.76M $11.49M $8.325M
YoY Change 35.12% 37.96%
Long-Term Investments
YoY Change
Other Assets $202.0K $143.0K $121.0K
YoY Change 98.04% 18.18%
Total Long-Term Assets $20.07M $20.39M $16.32M
YoY Change 22.67% 24.97% 980.66%
TOTAL ASSETS
Total Short-Term Assets $18.72M $22.49M $13.66M
Total Long-Term Assets $20.07M $20.39M $16.32M
Total Assets $38.79M $42.89M $29.97M
YoY Change 15.58% 43.08% 115.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.052M $1.517M $1.721M
YoY Change -21.35% -11.85% 93.37%
Accrued Expenses $3.686M $3.627M $3.834M
YoY Change 32.49% -5.4% 13.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $247.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due $6.171M $6.957M $1.234M
YoY Change 66.65% 463.78%
Total Short-Term Liabilities $15.27M $16.60M $10.10M
YoY Change -6.49% 64.29% 136.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $448.0K $7.405M
YoY Change -100.0% -93.95%
Other Long-Term Liabilities $1.089M $1.163M $974.0K
YoY Change -12.81% 19.4% 178.29%
Total Long-Term Liabilities $1.089M $1.611M $8.379M
YoY Change -82.4% -80.77% 2294.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.27M $16.60M $10.10M
Total Long-Term Liabilities $1.089M $1.611M $8.379M
Total Liabilities $18.52M $20.31M $29.68M
YoY Change -17.75% -31.57% 541.1%
SHAREHOLDERS EQUITY
Retained Earnings -$151.8M -$149.3M -$144.2M
YoY Change 6.29% 3.57%
Common Stock $64.00K $721.0K $499.0K
YoY Change -87.23% 44.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.27M $22.58M -$1.505M
YoY Change
Total Liabilities & Shareholders Equity $38.79M $42.89M $29.97M
YoY Change 15.58% 43.08% 115.02%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$2.314M -$2.754M -$1.270M
YoY Change -976.52% 116.85% 41.43%
Depreciation, Depletion And Amortization $710.0K $495.0K $481.0K
YoY Change 20.34% 2.91% 243.57%
Cash From Operating Activities -$2.420M -$2.580M -$990.0K
YoY Change -316.07% 160.61% 16.47%
INVESTING ACTIVITIES
Capital Expenditures -$390.0K -$3.680M $70.00K
YoY Change 387.5% -5357.14% -333.33%
Acquisitions
YoY Change
Other Investing Activities $3.890M $4.780M -$120.0K
YoY Change -19550.0% -4083.33% 1100.0%
Cash From Investing Activities $3.500M $1.090M -$40.00K
YoY Change -3281.82% -2825.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.320M -100.0K -160.0K
YoY Change -152.17% -37.5% 166.67%
NET CHANGE
Cash From Operating Activities -2.420M -2.580M -990.0K
Cash From Investing Activities 3.500M 1.090M -40.00K
Cash From Financing Activities -1.320M -100.0K -160.0K
Net Change In Cash -240.0K -1.590M -1.190M
YoY Change -106.78% 33.61% 25.26%
FREE CASH FLOW
Cash From Operating Activities -$2.420M -$2.580M -$990.0K
Capital Expenditures -$390.0K -$3.680M $70.00K
Free Cash Flow -$2.030M $1.100M -$1.060M
YoY Change -269.17% -203.77% 29.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2609000 USD
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1517000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8157000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7573000 USD
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3627000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2782000 USD
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12490000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11969000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
0 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
336000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
434000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
152987000 USD
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170706000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
556000 USD
CY2012Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
16172408 shares
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1088000 USD
CY2011Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1479000 USD
CY2010Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
334000 USD
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1236000 USD
CY2011Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1387000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1576000 USD
CY2011Q3 us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
113000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
339000 USD
us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
1161000 USD
us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
287000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2011Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17751940 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29269699 shares
CY2011Q4 us-gaap Assets
Assets
33562000 USD
CY2012Q3 us-gaap Assets
Assets
42887000 USD
CY2011Q3 us-gaap Assets
Assets
29974000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
22494000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
17198000 USD
CY2012Q3 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
200000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4747000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4946000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3454000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1423000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-199000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2031000 USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49625725 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71645725 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19000000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71645725 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49625725 shares
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
721000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
501000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2666000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1326000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9959000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5916000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12722000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10248000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4089000 USD
CY2011Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3808000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3000000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1377000 USD
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1279000 USD
us-gaap Depreciation
Depreciation
500000 USD
CY2012Q3 us-gaap Depreciation
Depreciation
200000 USD
CY2011Q3 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation
Depreciation
500000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1570000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1506000 USD
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
495000 USD
CY2011Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
481000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1113000 USD
CY2011Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11200000 USD
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
10600000 USD
CY2011Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
600000 USD
CY2012Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1095000 USD
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
495000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
34000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
72000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0148
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1133000 USD
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1058000 USD
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y6M
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.55
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0054
CY2011Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
600000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
6866000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9403000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9000 USD
CY2010Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4334000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1437000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2315000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1700000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13800000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11485000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7966000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
6674000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
6440000 USD
us-gaap Gross Profit
GrossProfit
13152000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
3800000 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
4445000 USD
us-gaap Gross Profit
GrossProfit
11466000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2640000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5926000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10165000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1279000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-120000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-18000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
44000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
106000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
616000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
137000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2153000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1418000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-403000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-131000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-33000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
268000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
377000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
269000 USD
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11485000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7966000 USD
us-gaap Interest Paid
InterestPaid
495000 USD
us-gaap Interest Paid
InterestPaid
753000 USD
CY2012Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3333000 USD
CY2011Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2608000 USD
CY2012Q3 us-gaap Inventory Gross
InventoryGross
4987000 USD
CY2011Q4 us-gaap Inventory Gross
InventoryGross
4370000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
3859000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
4406000 USD
CY2011Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
511000 USD
CY2011Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
514000 USD
CY2011Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
520000 USD
CY2012Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
581000 USD
CY2012Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
559000 USD
CY2010Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
518000 USD
CY2012Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1563000 USD
CY2011Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1485000 USD
us-gaap Inventory Write Down
InventoryWriteDown
88000 USD
us-gaap Inventory Write Down
InventoryWriteDown
47000 USD
CY2011Q3 us-gaap Inventory Write Down
InventoryWriteDown
-2000 USD
CY2012Q3 us-gaap Inventory Write Down
InventoryWriteDown
35000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16600000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
22514000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
20311000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33562000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42887000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16328000 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3703000 USD
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6957000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4937000 USD
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
448000 USD
CY2012Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10819000 USD
CY2011Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10143000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-801000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15922000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-403000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8378000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-899000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7777000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10045000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-2754000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-1270000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6014000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6509000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10848000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2919000 USD
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1545000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
175000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
388000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
us-gaap Operating Expenses
OperatingExpenses
15962000 USD
us-gaap Operating Expenses
OperatingExpenses
17702000 USD
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
4884000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
6227000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2810000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6236000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-439000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2427000 USD
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
300000 USD
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
900000 USD
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1000000 USD
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1100000 USD
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1100000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
820000 USD
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1186000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
102000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
98000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-56000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
86000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
88000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
88000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
98000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-56000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
86000 USD
CY2012Q3 us-gaap Other Inventory Demo
OtherInventoryDemo
91000 USD
CY2011Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
277000 USD
CY2012Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1067000 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1042000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1249000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1163000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
231000 USD
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
256000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
345000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1500000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3394000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
641000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
8994000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
495000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
803000 USD
CY2011Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
275000 USD
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2012Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
165000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
450000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
495000 USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
26000 USD
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
26000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications.</font></div><div style="line-height:120%;padding-top:18px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified in order to conform to the current year presentation regarding segment reporting.</font></div></div>
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17483000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4996000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13825000 USD
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14581000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2091000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1856000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1649000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1432000 USD
CY2012Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
679000 USD
CY2011Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
205000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
165000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
244000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
659000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1317000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
515000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
668000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1650000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1870000 USD
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2011Q3 us-gaap Restructuring Charges
RestructuringCharges
5000 USD
us-gaap Restructuring Charges
RestructuringCharges
40000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-149311000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142802000 USD
CY2012Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
7889000 USD
CY2011Q3 us-gaap Sales Revenue Net
SalesRevenueNet
8253000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
24188000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
23400000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14272000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4364000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5559000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15832000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
734000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
556000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.14
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2752471 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
25500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
439000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
477500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
626500 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4172000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4314000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.10
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.50
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.42
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.20
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.03
CY2012Q3 us-gaap Share Price
SharePrice
0.95
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2011Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3082000 USD
CY2012Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
3998000 USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2012Q3 us-gaap Significant Purchase Commitment Remaining Minimum Amount Committed
SignificantPurchaseCommitmentRemainingMinimumAmountCommitted
3000000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17373000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
11048000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
22576000 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
CY2011Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
600000 USD
CY2012Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0 USD
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
6866000 USD
CY2012Q3 tbio Stock Warrants Expense
StockWarrantsExpense
0 USD
tbio Stock Warrants Expense
StockWarrantsExpense
-1000000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these consolidated financial statements.</font></div></div>
CY2012Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2100000 USD
CY2011Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2012Q3 tbio Accounts Receivable Domestic Extended Payment Terms
AccountsReceivableDomesticExtendedPaymentTerms
P90D
CY2012Q3 tbio Accounts Receivable General Payment Terms
AccountsReceivableGeneralPaymentTerms
P30D
CY2012Q3 tbio Accounts Receivable International Extended Payment Terms Greater Than
AccountsReceivableInternationalExtendedPaymentTermsGreaterThan
P90D
tbio Acquisition Of Intangible Assets
AcquisitionOfIntangibleAssets
1007000 USD
tbio Acquisition Of Intangible Assets
AcquisitionOfIntangibleAssets
0 USD
tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
-1000000 USD
tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
0 USD
tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
68669229 shares
CY2012Q3 tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
71645725 shares
CY2011Q3 tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
49327527 shares
tbio Basic And Diluted Weighted Average Shares Of Common Stock Outstanding
BasicAndDilutedWeightedAverageSharesOfCommonStockOutstanding
49306861 shares
CY2012Q3 tbio Class Of Warrant Or Right Exercise Term
ClassOfWarrantOrRightExerciseTerm
P5Y
tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
11000000 shares
CY2012Q3 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
0 shares
CY2012Q1 tbio Convertible Notes Number Of Securities Called By Note
ConvertibleNotesNumberOfSecuritiesCalledByNote
3000000 shares
tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
0.25
CY2011Q4 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3682000 USD
CY2012Q3 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3762000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-713000 USD
CY2012Q3 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-207000 USD
CY2011Q3 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-238000 USD
tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-720000 USD
tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
51000 USD
tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
18000 USD
CY2011Q3 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
4000 USD
CY2012Q3 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
13000 USD
tbio Issuance Of Warrants Expected Exercise Period
IssuanceOfWarrantsExpectedExercisePeriod
P4Y4M6D
CY2012Q3 tbio Number Of Wave Systems
NumberOfWaveSystems
1550 WAVE_Systems
CY2012Q3 tbio Operating Leases Future Minimum Payments Due In Six Years
OperatingLeasesFutureMinimumPaymentsDueInSixYears
800000 USD
tbio Other Income Expense
OtherIncomeExpense
310000 USD
tbio Other Income Expense
OtherIncomeExpense
-7355000 USD
CY2012Q3 tbio Other Income Expense
OtherIncomeExpense
-213000 USD
CY2011Q3 tbio Other Income Expense
OtherIncomeExpense
-840000 USD
CY2012Q1 tbio Private Placement Event Of Ineffective Registration Statement Anniversary Period
PrivatePlacementEventOfIneffectiveRegistrationStatementAnniversaryPeriod
P30Y
CY2012Q1 tbio Private Placement Event Of Ineffective Registration Statement Percentage Of Aggregate Purchase Price
PrivatePlacementEventOfIneffectiveRegistrationStatementPercentageOfAggregatePurchasePrice
0.015
CY2012Q1 tbio Private Placement Event Of Ineffective Registration Statement Percentage Of Purchase Price
PrivatePlacementEventOfIneffectiveRegistrationStatementPercentageOfPurchasePrice
0.1
CY2012Q1 tbio Proceeds From Issuance Of Common Stock And Convertable Notes
ProceedsFromIssuanceOfCommonStockAndConvertableNotes
22000000 USD
tbio Share Based Compensation Arrangement By Share Based Payment Award Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardContractualTerm
P10Y
tbio Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0388
CY2012Q3 tbio Stock And Warrants Exercised During Period Shares Preferred Stock And Warrants
StockAndWarrantsExercisedDuringPeriodSharesPreferredStockAndWarrants
0 shares
tbio Stock And Warrants Exercised During Period Shares Preferred Stock And Warrants
StockAndWarrantsExercisedDuringPeriodSharesPreferredStockAndWarrants
0 shares
tbio Stock And Warrants Issued During Period Shares Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants
0 shares
CY2012Q3 tbio Stock And Warrants Issued During Period Shares Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants
0 shares
CY2011Q3 tbio Stock Warrants Expense
StockWarrantsExpense
0 USD
tbio Stock Warrants Expense
StockWarrantsExpense
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71645725 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC

Files In Submission

Name View Source Status
0001043961-12-000016-index-headers.html Edgar Link pending
0001043961-12-000016-index.html Edgar Link pending
0001043961-12-000016.txt Edgar Link pending
0001043961-12-000016-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20120930.xml Edgar Link completed
tbio-20120930.xsd Edgar Link pending
tbio-20120930x10q.htm Edgar Link pending
tbio-20120930_cal.xml Edgar Link unprocessable
tbio-20120930_def.xml Edgar Link unprocessable
tbio-20120930_lab.xml Edgar Link unprocessable
tbio-20120930_pre.xml Edgar Link unprocessable
tbio-axialassetpurchaseagr.htm Edgar Link pending
tbio-ex311_2012930xq3.htm Edgar Link pending
tbio-ex312_2012930xq3.htm Edgar Link pending
tbio-ex321_2012930xq3.htm Edgar Link pending
tbio-ex322_2012930xq3.htm Edgar Link pending